Novoron Bioscience

Pioneering lipoprotein-receptor drug development to repair damage and degeneration to the brain, spinal cord and beyond.

Founded 2014

San Diego, United States 17 employees Seed Total: $17.99M Biopharma, Biotechnology +4

General Information

Company Name Novoron Bioscience

Founded Year 2014

Location

San Diego, United States

Founders / Decision Makers

Employees 17

Industries Biopharma, Biotechnology, Health Care +3

Funding Stage Seed

Business Model B2B, B2D

Revenue Model Licensing, Product Sales, Service Fee

Social

BounceWatch is an independent company data service, not affiliated with Novoron Bioscience. To contact Novoron Bioscience, visit novoron.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Novoron Bioscience compare?

A PDF of Novoron Bioscience and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Novoron Bioscience soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

From the desk

Is Novoron Bioscience on your competitive set?

Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.

Book a 7-day Readout

Discover More

United States Market

Market Signals All Companies

Biopharma

Industry Signals All Companies in United States

Novoron Bioscience Alternatives

All Signals Trend Reports

About Novoron Bioscience

Novoron Bioscience is carving a niche in the biotechnology sector by pioneering a novel approach to drug development focused on repairing neurological damage. Their innovative work with lipoprotein-receptor drugs targets severe conditions like multiple sclerosis, spinal cord injuries, and Alzheimer's disease. Founded in 2014, the company is based in the United States and plays a significant role in the Biopharma and Pharmaceutical industries.

Their commitment to addressing some of the most intractable neurological diseases underscores their potential impact in the Health Care and Life Sciences fields. With a recent financial boost of $125.00K through a Convertible Note investment in August 2021 from Two Bear Capital, Novoron Bioscience is positioned to further its research and development efforts, maintaining strong progression in a highly competitive market.

Business keywords: Lipoprotein-receptor drug development, Neurological condition treatment, Central nervous system therapeutics, Multiple sclerosis research, Spinal cord injury treatment, Alzheimer's disease therapy, Neuronal regeneration, Remyelination techniques, Orphan drug development, Demyelinating conditions, Tauopathy solutions, Neuroscience innovation, CNS pathologies

Services & Products

Development of innovative therapies

Maximized therapeutic benefit exploration

Discovery and development of new drug modalities

Target Customers

Patients with brain and spinal cord injuries Individuals experiencing neurodegeneration Healthcare providers and researchers in neurology

Funding Rounds & Investors (11)

View All

Funding Stage	Amount	Investors	Lead Investors	Date
Grant	$1.25M	1	National Institute on Aging (NIA)	01 Jun 2026
Grant	$2.50M	1	National Institute on Aging (NIA)	01 Jan 2026
Seed	$9.50M	-		01 Dec 2022
Seed	$3.00M	1	Two Bear Capital	01 Nov 2021
Grant	$710.00K	1	National Institute of Health	01 Apr 2019
Seed	Undisclosed	1	Backstage Capital	01 Mar 2018
Grant	$680.00K	-		01 Dec 2015
Grant	$40.00K	-		01 Sep 2015
Grant	$80.00K	-		01 Apr 2015
Grant	$230.00K	-		01 Aug 2014

View All 11 Funding Rounds

Novoron Bioscience Alternatives & Competitors

View All Alternatives

Novoron Bioscience vs

ReNetX Bio United States

Pioneering therapeutics to address injuries and damages in the central nervous system, including spi...

Venture round

3 employees

Biotechnology, Health Care

Novoron Bioscience vs

Hemera Pharma Italy

A University of Verona and Milan spin-offs specialized in regenerative medicine for neurological dis...

11 employees

Biotechnology, Health and Wellness

Novoron Bioscience vs

Umecrine Cognition AB Sweden

A novel and safe approach for treating cognitive disorders

Convertible Note

11 employees

Biotechnology, Health Care

View all alternatives

FAQ About Novoron Bioscience

Pioneering lipoprotein-receptor drug development to repair damage and degeneration to the brain, spinal cord and beyond.

Novoron Bioscience was founded in 2014.

Novoron Bioscience is headquartered in San Diego, United States.

Novoron Bioscience operates in Biopharma, Biotechnology, Health Care, Health and Wellness, Life Sciences and Pharmaceutical. Its work centres on Lipoprotein-receptor drug development, Neurological condition treatment, Central nervous system therapeutics and Multiple sclerosis research. Its customers include Patients with brain and spinal cord injuries, Individuals experiencing neurodegeneration and Healthcare providers and researchers in neurology.

Novoron Bioscience has a B2B and B2D business model. Its revenue comes from Licensing, Product Sales and Service Fee.

Novoron Bioscience has approximately 17 employees.

Novoron Bioscience has completed 11 funding rounds, raising a total of $17.99M. The latest funding stage is Seed.

Novoron Bioscience offers: Development of innovative therapies, Maximized therapeutic benefit exploration, Discovery and development of new drug modalities.

Top alternatives and competitors to Novoron Bioscience include ReNetX Bio, Hemera Pharma, Umecrine Cognition AB, Disarm Therapeutics, Vertero Therapeutics, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Novoron Bioscience and ReNetX Bio are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Novoron Bioscience, https://bouncewatch.com/company/novoron-bioscience, updated 19 July 2026. When citing, please name BounceWatch and link this page.